Clinical trial · Interventional
Robot-Assisted Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a Stage
Robot-Assisted Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a Stage : Clinical Outcomes of a Randomised Controlled Trial
NCT02924597CI-TRIAL-00024154unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To evaluate the feasibility and efficiency of zero ischemia robot-assisted laparoscopic radio frequency ablation assisted enucleation of T1a renal cell carcinoma in comparison with robot-assisted laparoscopic partial nephrectomy without hilar clamping.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Renal Cell Carcinoma | Renal Cell Carcinoma | CURATED_BROADER | 0.80 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| zero ischemia robot-assisted laparoscopic partial nephrectomy | Procedure | — | UNRESOLVED |
| zero ischemia robot-assisted laparoscopic RFA assisted TE | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Robot-assisted laparoscopic RFA assisted TE
- description
- RFA will be performed for 1 to 4 cycles for 4 to 12 minutes each depending on tumor size and depth. The tumor then will be laparoscopic enucleation without hilar clamping.
- interventionNames
- Procedure: zero ischemia robot-assisted laparoscopic RFA assisted TE
- type
- ACTIVE_COMPARATOR
- label
- Robot-Assisted laparoscopic partial nephrectomy
- description
- The tumor then will be laparoscopic enucleation without hilar clamping.
- interventionNames
- Procedure: zero ischemia robot-assisted laparoscopic partial nephrectomy
Primary outcomes (2)
- measure
- The absolute change in glomerular filtration rate (GFR) of the affected kidney
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 15 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * patients with sporadic, unilateral, newly diagnosed T1a presumed renal cell carcinoma * patients scheduled for robot-assisted laparoscopic nephron sparing surgery * patients with normal contralateral renal function (differential renal function of \>40% as determined by radionuclide scintigraphy) * patients agreeable to participate in this long-term follow-up study Exclusion Criteria: * patients' aged \>80 years * patients with other renal diseases,(including kidney stone, glomerular nephritis, etc.) which might affect the renal function of the operative kidney * patients not able to tolerate the robot-assisted laparoscopic procedure * patients with previous renal surgery or history of any inflammatory conditions of the operative kidney * patients with the renal tumor involving urinary collecting system
References
Publications (0)
Data not yet available
No reference posted for this study.